BC
KYNB icon

Brinker Capital’s Kyntra Bio KYNB Stock Holding History

Brinker Capital’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		$903K Buy
891
+17
+2% +$15.8K 0.03% 529
2020
Q1 		$760K Buy
874
+187
+27% +$186K 0.03% 509
2019
Q4 		$736K Sell
687
-27
-4% -$27.6K 0.02% 607
2019
Q3 		$660K Buy
714
+81
+13% +$89K 0.02% 624
2019
Q2 		$715K Buy
633
+4
+0.6% +$4.38K 0.03% 591
2019
Q1 		$854K Buy
+629
New +$853K 0.03% 512

Other funds holding KYNB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Brinker Capital's KYNB Position: Q2 2020 in Review

Brinker Capital increased its Kyntra Bio (KYNB) stake by 1.9% in Q2 2020, buying an estimated $15.8K and bringing the position to 891 shares worth $903K. The position accounts for 0.03% of the portfolio, ranked #529.

Brinker Capital first reported a position in KYNB in Q1 2019 and has held it in 6 quarters since. 194 funds tracked by Wall St. Rank hold KYNB as of Q2 2020.

  • Brinker Capital held 891 shares of Kyntra Bio worth $903K as of Q2 2020.
  • Brinker Capital bought 17 Kyntra Bio shares in Q2 2020, an estimated $15.8K.
  • Kyntra Bio made up 0.03% of Brinker Capital's portfolio in Q2 2020, its #529 holding.
  • Brinker Capital first reported a position in Kyntra Bio in Q1 2019 and has held it in 6 quarters since.
  • 194 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2020.

Based on Brinker Capital's 13F filing for Q2 2020, filed 30 Jul 2020.